首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Hereditary hyper-ACE-emia due to the Pro1199Leu mutation of somatic ACE as a potential pitfall in diagnosis: a first family outside Europe.
【24h】

Hereditary hyper-ACE-emia due to the Pro1199Leu mutation of somatic ACE as a potential pitfall in diagnosis: a first family outside Europe.

机译:由于体细胞ACE的Pro1199Leu突变导致的遗传性高ACE血症是诊断的潜在陷阱:欧洲以外的第一个家庭。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Elevated plasma levels of angiotensin converting enzyme (ACE) are associated with granulomatous diseases. However, several families of autosomal dominant hyper-ACE-emia without disease association have already been reported. Recently, the ACE mutation c.3705C>T (Pro1199Leu) was identified as the genetic correlate in European cases of asymptomatic autosomal dominant hyper-ACE-emia. Here, we describe a first family outside Europe with asymptomatic autosomal-dominant hyper-ACE-emia due to the ACE Pro1199Leu mutation. Benign autosomal-dominant hyper-ACE-emia should be considered for differential diagnosis of elevated ACE levels worldwide.
机译:血浆血管紧张素转化酶(ACE)水平升高与肉芽肿性疾病有关。但是,已经报道了几类常染色体显性高ACE血症而无疾病关联。最近,ACE突变c.3705C> T(Pro1199Leu)被确定为欧洲无症状常染色体显性高ACE血症病例的遗传相关因素。在这里,我们描述了由于ACE Pro1199Leu突变而导致的无症状常染色体显性高ACE血症的欧洲以外的第一个家庭。良性常染色体显性高ACE血症应用于全球ACE水平升高的鉴别诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号